Andre Choulika Ph.D. is a prominent figure in the biopharmaceutical industry, serving as the Chairman and CEO of Cellectis since December 1999, where the focus is on developing engineered T-cell therapies for cancer treatment. Additionally, Andre Choulika is a member of the Board of Directors at Institut Pasteur and has held positions such as Chairman of the Board at Calyxt, Inc. and President of France Biotech. Previous roles include CEO of Scéil and Research Fellow at both Institut Pasteur and Children's Hospital Boston. Andre Choulika's educational background includes a Ph.D. in Molecular Virology from Pierre and Marie Curie University, a Post-Doctoral Fellowship at Harvard Medical School, and management training in Start-Up Companies from HEC Paris.
This person is not in the org chart
This person is not in any teams
This person is not in any offices